ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma.
about
Targeting LKB1 in cancer - exposing and exploiting vulnerabilitiesCaenorhabditis elegans unc-82 encodes a serine/threonine kinase important for myosin filament organization in muscle during growth.Large differences in global transcriptional regulatory programs of normal and tumor colon cellsNDR2 acts as the upstream kinase of ARK5 during insulin-like growth factor-1 signaling.The molecular classification of multiple myelomaMNK1-induced eIF-4E phosphorylation in myeloma cells: a pathway mediating IL-6-induced expansion and expression of genes involved in metabolic and proteotoxic responsesThe orchestration of mammalian tissue morphogenesis through a series of coherent feed-forward loops.Genome-wide assessment of recurrent genomic imbalances in canine leukemia identifies evolutionarily conserved regions for subtype differentiation.Genetic events in the pathogenesis of multiple myeloma.The molecular characterization and clinical management of multiple myeloma in the post-genome era.microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.Association of Chromosomal Translocation and MiRNA Expression with The Pathogenesis of Multiple Myeloma.MAF protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma.Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma.Therapeutic potential of targeting IRES-dependent c-myc translation in multiple myeloma cells during ER stress.Next-generation sequencing identifies TGF-β1-associated gene expression profiles in renal epithelial cells reiterated in human diabetic nephropathyARK5 is associated with the invasive and metastatic potential of human breast cancer cells.Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myeloma.CD13/APN transcription is regulated by the proto-oncogene c-Maf via an atypical response element.GSK3-mediated MAF phosphorylation in multiple myeloma as a potential therapeutic targetΗypoxia-inducible factor 1-α promotes colon cell proliferation and migration by upregulating AMPK-related protein kinase 5 under hypoxic conditions.
P2860
Q26801412-A5191025-87D6-444E-B962-3E3A4BF75B1DQ33628552-E0BAD2E3-B7A4-4419-9E56-A73E66AC3C0AQ34278484-607313B1-0638-45F9-875E-892507BC57FEQ34495942-376E7472-AE95-483E-A561-AA0225464CE3Q34530992-61C73FF2-7639-48B1-AFC7-3941B23E73F2Q35142765-811118F8-3AA9-40B1-AE48-D7C3CB8FD95AQ35604583-53B88AB1-0A96-4DD0-9EA5-546B3FADC33AQ35650512-530AED6F-14D2-45BA-9E5D-8169E19E5D69Q36380235-BF78037C-8B94-4A25-8AEF-2B627FFD840FQ36939043-D307FE46-589E-41C9-B1DB-3E104D39779EQ36946761-BAE4252E-BCE9-426D-85A3-5B186EF95C53Q38190971-EB4B6364-71EB-4C69-82D3-63CE70F7DC5EQ38735514-A12FA7F3-BB7D-411B-B418-3D1D58CBA988Q38794408-1104E0D0-8366-4DF7-8CF7-63125F1C4B87Q38876640-B846BC3F-7A72-40A9-8D28-BA7916C4787EQ39408463-C98B41E1-C4C4-4D1C-814B-AAE3BE566650Q39439080-F2D5DC01-3E79-4F5E-814C-22A20D003191Q39943302-A1429999-96E8-4689-9AB4-EF62B2385F17Q40075882-FBCFB51A-D918-4333-9692-8D688A03E5A0Q41914138-99944194-F35F-448C-977E-D7C0D3731509Q50231063-2C1D488C-82D7-4ECB-8805-EE62BF1519F8
P2860
ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
ARK5 is transcriptionally regu ...... of malignant multiple myeloma.
@ast
ARK5 is transcriptionally regu ...... of malignant multiple myeloma.
@en
ARK5 is transcriptionally regu ...... of malignant multiple myeloma.
@nl
type
label
ARK5 is transcriptionally regu ...... of malignant multiple myeloma.
@ast
ARK5 is transcriptionally regu ...... of malignant multiple myeloma.
@en
ARK5 is transcriptionally regu ...... of malignant multiple myeloma.
@nl
prefLabel
ARK5 is transcriptionally regu ...... of malignant multiple myeloma.
@ast
ARK5 is transcriptionally regu ...... of malignant multiple myeloma.
@en
ARK5 is transcriptionally regu ...... of malignant multiple myeloma.
@nl
P2093
P2860
P356
P1433
P1476
ARK5 is transcriptionally regu ...... of malignant multiple myeloma.
@en
P2093
Atsushi Suzuki
Emi Tajima
Fenghuang Zhan
Hiroyasu Esumi
Ichiro Hanamura
John Shaughnessy
Miyuki Kato-Uranishi
Ryuzo Ueda
Satoru Takahashi
Shinsuke Iida
P2860
P2888
P304
P356
10.1038/SJ.ONC.1208844
P407
P577
2005-10-01T00:00:00Z
P5875
P6179
1036612922